Market research
JYNT The Joint Corp
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 99M
- P/E ratio
- 50.21
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 1.09
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- Not available
- Market cap
- 99M
- P/E ratio
- 50.21
- Analyst target
- 10
- Dividend yield
- Not available
- Beta
- 1.09
About
About The Joint Corp
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Research context
The Joint Corp appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the JYNT discussion.
5 years, 7 months ago
The Joint Corp is currently in a long term uptrend where the price is trading 100.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.6.
The Joint Corp's total revenue rose by 22.8% to $17M since the same quarter in the previous year.
Its net income has increased by 723.1% to $11M since the same quarter in the previous year.
Finally, its free cash flow grew by 47.3% to $2M since the same quarter in the previous year.
Based on the above factors, The Joint Corp gets an overall score of 5/5.